Definium Therapeutics, Inc. (DFTX) — Capital Reinvestment Ratio

Latest as of June 2019: 0.00x

Definium Therapeutics, Inc. (DFTX) has a Capital Reinvestment Ratio of 0.00x as of June 2019, meaning it reinvests 0% of its operating cash flow ($24.19K) in capital expenditures ($0.11). See Definium Therapeutics, Inc. (DFTX) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$24.19K
USD

Capital Expenditures

$0.11
USD

Data as of

Jun 2019
Most recent filing

Annual Capital Reinvestment Ratio for Definium Therapeutics, Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Definium Therapeutics, Inc. from None to None. For live market cap and broader valuation context, see market cap of Definium Therapeutics, Inc..

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow